Biomater Sci
Some wellness therapies are used daily, while others may be used as needed
The Company has 8,396,600 warrants outstanding from prior financings EMCs Position in the Company Emerging Markets Consulting participated directly in this financing by investing: CAD $671,356 Purchasing: 1,342,712 shares at CAD $0.50 per share, representing approximately 33.6% of the CAD $2,000,000 offering (Note: $671,356 of a $2,000,000 round is 33.6%.) In addition, we separately acquired: 1,000,000 additional shares through a private transaction EMCs total holding of 2,342,712 shares represents approximately 4.47% of the 52,431,207 common shares outstanding
Some clinicians move patients through a progression: start with Sermorelin to establish tolerability and baseline response
Therefore, the debate between a B12 shot vs pill isn't a one-size-fits-all scenario
However, short-term NSAID use (few days) unlikely causing significant problems